The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 12, 2022
Filed:
Sep. 10, 2015
Applicant:
Genentech, Inc., South San Francisco, CA (US);
Inventors:
Daniel Shin-Yu Chen, Burlingame, CA (US);
Priti Hegde, San Mateo, CA (US);
Hartmut Koeppen, San Mateo, CA (US);
Marcin Kowanetz, San Francisco, CA (US);
Assignee:
Genentech, Inc., South San Francisco, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); C12Q 1/6886 (2018.01); G01N 33/68 (2006.01); G06Q 30/02 (2012.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57484 (2013.01); G01N 33/57492 (2013.01); G01N 33/6854 (2013.01); G01N 33/6869 (2013.01); G06Q 30/0251 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01); G01N 2333/5412 (2013.01); G01N 2333/70532 (2013.01); G01N 2800/52 (2013.01);
Abstract
Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.